QFP
AMRX icon

Quantum Financial Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Quantum Financial Partners’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$178K Buy
+10,300
New +$141K 0.09% 150

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Quantum Financial Partners's AMRX Position: Q2 2026 in Review

Quantum Financial Partners opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 10,300 shares worth $178K. The stake represents 0.09% of the portfolio and ranks #150 among its holdings.

39 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Quantum Financial Partners held 10,300 shares of Amneal Pharmaceuticals worth $178K as of Q2 2026.
  • Amneal Pharmaceuticals was a new Quantum Financial Partners position in Q2 2026.
  • Amneal Pharmaceuticals made up 0.09% of Quantum Financial Partners's portfolio in Q2 2026, its #150 holding.
  • 39 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Quantum Financial Partners's 13F filing for Q2 2026, filed 20 Jul 2026.